Related Topics
 
Larisa Debelenko, MD, PhD.

Larisa V. Debelenko, MD, PhD

Assistant Member, St. Jude Faculty

Departments

Pathology

Contact Information

Larisa Debelenko, MD, PhD
Pathology
MS 250, Room C-5027
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: larisa.debelenko@stjude.org
Phone: (901) 595-3520
FAX: (901) 595-3100

Education

MD - Bogomolets Medical Institute, Kiev, Ukraine (1983)
PhD - Bogomolets Medical Institute, Kiev, Ukraine (1986)


Research Interests

  • Pathology and translational research in pediatric solid tumors, especially pediatric sarcoma and endocrine tumors

Selected Publications

Srinivasan A, Wickes BL, Romanelli AM, Debelenko L, Rubnitz JE, Sutton DA, Thompson EH, Fothergill AW, Rinaldi MG, Hayden RT, Shenep JL. Cutaneous Infection Caused by Macrophomina phaseolina in a Child with Acute Myeloid Leukemia. J Clin Microbiol 2009 (in press).

Srinivasan A, Kleiman MB, Debelenko L, Stokes DC, De Vincenzo J, Wheat LJ. False-negative Histoplasma antigen in acute pulmonary histoplasmosis: The value of urinary concentration by ultrafiltration and heat denaturation of serum proteins in detection of Histoplasma antigen. Pediatric Infectious Disease J 28:447-449, 2009.

Florez-Vargas A, Vargas So, Debelenko LV, Perez-Atayde AR, Kozakewich HPW, Zurakowsly D. Comparison between D2-40 and LYVE-1 in skin lymphatic malformations. Lymphology 41(3):103-10, 2008.

Gleason BC, Kleinman PK, Debelenko LV, Rahbar R, Gebhardt MC, Perez-Atayde AR. Novel karyotypes in giant-cell rich lesions of bone. Am J Surg Pathol 31(6):926-32, 2007.

Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HPW.  D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Modern Pathol 18(11):1454-1460, 2005.

Debelenko LV, Arthur  DC, Pack SD, Helman LJ, Schrump DS, Tsokos M. Identification of CARS-ALK  fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest 83(9):1255-1265, 2003.

Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi S-E, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR. Identification of MEN gene mutations in sporadic carcinoid tumors of the lung. Human Molecular Genetics 6:2285-2290, 1997.

Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Research 57:2238-2243, 1997. 

Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, Guru SC, Kester MB, Olufemi S-E, Agarwal SK, Burns AL, Spiegel AM, Collins FS, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Chandrasekharappa SC, Debelenko LV. Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Research 57:1855-1858, 1997.

Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia - type 1. Science 276:404-40, 1997.

Debelenko LV, Emmert-Buck MR, Manickam P, Kester MB, Guru SC, DiFranco EM, Olufemi S-E, Agarwal S, Lubensky IA, Zhuang Z, Burns AL, Spiegel AM, Liotta LA , Collins FS, Marx SJ, Chandrasekharappa SC. Haplotype analysis defines a new minimal interval for the multiple endocrine neoplasia type 1 (MEN1). Cancer Research 57:1039-1042, 1997.

Last update: June 2009

Email This Article Email This Article   |   Print Print